Lifespan-extending effects of royal jelly and its related substances on the nematode Caenorhabditis elegans

PLoS One. 2011;6(8):e23527. doi: 10.1371/journal.pone.0023527. Epub 2011 Aug 9.

Abstract

Background: One of the most important challenges in the study of aging is to discover compounds with longevity-promoting activities and to unravel their underlying mechanisms. Royal jelly (RJ) has been reported to possess diverse beneficial properties. Furthermore, protease-treated RJ (pRJ) has additional pharmacological activities. Exactly how RJ and pRJ exert these effects and which of their components are responsible for these effects are largely unknown. The evolutionarily conserved mechanisms that control longevity have been indicated. The purpose of the present study was to determine whether RJ and its related substances exert a lifespan-extending function in the nematode Caenorhabditis elegans and to gain insights into the active agents in RJ and their mechanism of action.

Principal findings: We found that both RJ and pRJ extended the lifespan of C. elegans. The lifespan-extending activity of pRJ was enhanced by Octadecyl-silica column chromatography (pRJ-Fraction 5). pRJ-Fr.5 increased the animals' lifespan in part by acting through the FOXO transcription factor DAF-16, the activation of which is known to promote longevity in C. elegans by reducing insulin/IGF-1 signaling (IIS). pRJ-Fr.5 reduced the expression of ins-9, one of the insulin-like peptide genes. Moreover, pRJ-Fr.5 and reduced IIS shared some common features in terms of their effects on gene expression, such as the up-regulation of dod-3 and the down-regulation of dod-19, dao-4 and fkb-4. 10-Hydroxy-2-decenoic acid (10-HDA), which was present at high concentrations in pRJ-Fr.5, increased lifespan independently of DAF-16 activity.

Conclusions/significance: These results demonstrate that RJ and its related substances extend lifespan in C. elegans, suggesting that RJ may contain longevity-promoting factors. Further analysis and characterization of the lifespan-extending agents in RJ and pRJ may broaden our understanding of the gene network involved in longevity regulation in diverse species and may lead to the development of nutraceutical interventions in the aging process.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Active Transport, Cell Nucleus / drug effects
  • Aging / drug effects*
  • Aging / genetics
  • Aging / physiology
  • Animals
  • Bees / chemistry
  • Caenorhabditis elegans / drug effects*
  • Caenorhabditis elegans / genetics
  • Caenorhabditis elegans / physiology
  • Caenorhabditis elegans Proteins / genetics
  • Caenorhabditis elegans Proteins / metabolism
  • Cell Nucleus / metabolism
  • Chromatography / methods
  • Dose-Response Relationship, Drug
  • Fatty Acids / chemistry
  • Fatty Acids / metabolism
  • Fatty Acids / pharmacology*
  • Fatty Acids, Monounsaturated / pharmacology
  • Forkhead Transcription Factors
  • Gene Expression Profiling
  • Gene Expression Regulation / drug effects
  • Green Fluorescent Proteins / genetics
  • Green Fluorescent Proteins / metabolism
  • Longevity / drug effects*
  • Longevity / genetics
  • Longevity / physiology
  • Mutation
  • Oligonucleotide Array Sequence Analysis
  • Peptide Hydrolases / metabolism
  • Promoter Regions, Genetic / genetics
  • Reverse Transcriptase Polymerase Chain Reaction
  • Transcription Factors / genetics
  • Transcription Factors / metabolism

Substances

  • Caenorhabditis elegans Proteins
  • Fatty Acids
  • Fatty Acids, Monounsaturated
  • Forkhead Transcription Factors
  • Transcription Factors
  • daf-16 protein, C elegans
  • Green Fluorescent Proteins
  • 10-hydroxy-2-decenoic acid
  • Peptide Hydrolases
  • royal jelly

Associated data

  • GEO/GSE26094